Related Experiment Videos

Effect of normorphine and enkephalin on spontaneous potentials in the vas deferens

Insights

Narcotic agonists like normorphine and methionine-enkephalin do not affect spontaneous excitatory junction potentials in mouse vas deferens smooth muscle. This suggests these drugs selectively inhibit nerve-stimulated noradrenaline release, not spontaneous release.

Area of Science:

  • Neuropharmacology
  • Smooth Muscle Physiology
  • Autonomic Nervous System

Background:

  • Opioid receptors are present in the vas deferens.
  • Noradrenaline is a key neurotransmitter in regulating smooth muscle contraction.
  • Spontaneous neurotransmitter release occurs independently of nerve stimulation.

Purpose of the Study:

  • To investigate the effect of normorphine and methionine-enkephalin on spontaneous neurotransmission in the mouse vas deferens.
  • To differentiate the mechanisms of opioid action on stimulated versus spontaneous noradrenaline release.

Main Methods:

  • Intracellular recording of spontaneous excitatory junction potentials (SEJP) from mouse vas deferens smooth muscle.
  • Application of normorphine (1 muM) and methionine-enkephalin (0.5 muM).
  • Analysis of SEJP frequency and amplitude distribution.

Main Results:

  • Neither normorphine nor methionine-enkephalin altered the frequency or amplitude of SEJPs.
  • Opioid agonists did not inhibit spontaneous noradrenaline release.

Conclusions:

  • Opioid-induced depression of noradrenaline release in the vas deferens is not mediated by a reduction in spontaneous release.
  • The findings suggest a selective presynaptic mechanism for opioid inhibition of evoked neurotransmission.

Related Concept Videos